Main > RHEUMATOLOGY > USA. P. PsA>Treat>JAK Inh. Tab.

---

USA. P. PsA>Treat>JAK Inh. Tab.'s subsections
(*) USA Approval Date: 2017. 12.14
Company
Generic Name: Tofacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 06.28.
RTM
RTM Web-Site

USA. P. PsA>Treat>JAK Inh. Tab.'s products
This section has no products